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We report the design and synthesis of a tetraethylene glycol- (TEG-) based bidentate ligand functionalized with dihydrolipoic acid
(DHLA) and biotin (DHLA—TEG—biotin) to promote biocompatibility of luminescent quantum dots (QD’s). This new ligand
readilybindstoCdSe—ZnScore-shellQDsviasurfaceligandexchange.QDscappedwithamixtureofDHLAandDHLA—TEG—
biotin or polyethylene glycol- (PEG-) (molecular weight average ∼600) modiﬁed DHLA (DHLA—PEG600) and DHLA—TEG—
biotin are easily dispersed in aqueous buﬀer solutions. In particular, homogeneous buﬀer solutions of QDs capped with a mixture
of DHLA—PEG600 and DHLA—TEG—biotin that are stable over broad pH range have been prepared. QDs coated with mixtures
of DHLA/DHLA—TEG—biotin and with DHLA—PEG600/DHLA—TEG—biotin were tested in surface binding assays and the
results indicate that biotin groups on the QD surface interact speciﬁcally with NeutrAvidin-functionalized microtiter well plates.
Copyright © 2007 Kimihiro Susumu et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
Luminescent semiconductor nanocrystals, such as those
made of CdSe–ZnS core-shell quantum dots (QD’s), pro-
vide substantial advantages for use as stable ﬂuorophores
in biological assays and imaging. As synthesized by con-
ventional methods using high-temperature solution reaction
fromorganometallicprecursors,highlyluminescentQD’sare
capped with hydrophobic organic ligands primarily made
of a mixture of trioctylphosphine/trioctylphosphine oxide
(TOP/TOPO). Further surface modiﬁcation is required to
make them water-soluble and biocompatible. Methods re-
ported to date for achieving water solubility of such ma-
terials include silica coating [1], encapsulation of the na-
tive TOP/TOPO-capped QD’s within amphiphilic polymer
shells [2] or lipid micelles [3], and cap exchange of the native
TOP/TOPO caps with hydrophilic ligands [4–6]. The strat-
egy based on cap exchange with bifunctional ligands is rela-
tively simple to implement and has the potential to provide
compact hydrophilic QD’s, a desired property in targeted
studies, including ﬂuorescence resonance energy transfer-
(FRET-) based sensing and cellular uptake [7–11].
We have previously utilized readily available thioctic
acid and polyethylene glycols (PEGs) in simple esteriﬁca-
tion schemes, followed by reduction of the 1,2-dithiolane
to synthesize a series of PEG-terminated dihydrolipoic acid
(DHLA–PEG) capping substrates [12]. The cap exchange
reaction of TOP/TOPO-capped QD’s with these substrates
produced water-soluble nanocrystals that are stable over ex-
tended periods of time and over a relatively broad pH range,
from weakly acidic to basic conditions (pH 5∼12). Though
compactandstable,thoseligandslackspeciﬁcfunctionalend
groups and do not allow easy implementation of simple con-
jugation techniques, such as avidin-biotin binding.
In this study, we further expanded those ﬁndings and re-
port the design and synthesis of ligands functionalized with
a biotin end group. The designed ligands have a central
tetraethylene glycol (TEG) segment, a dithiol terminal group
for anchoring on the QD surface and a lateral biotin. Ap-
pending biotin at the end of surface-attached ligands should
permit the use of the ubiquitous avidin-biotin binding mo-
tif to conjugate QD’s to proteins and other biomolecules via
an avidin bridge. Cap exchange reactions were carried out
with mixed ligands and preliminary binding assays of the2 Journal of Biomedicine and Biotechnology
biotin-coated water-soluble QD’s to NeutrAvidin-function-
alizedsubstratesshowedthatspeciﬁccaptureoftheQD’sdue
to avidin-biotin interactions was achieved.
2. EXPERIMENTAL SECTION
All manipulations were carried out under dry nitrogen and
air-sensitive solids were handled in an MBraun Labmaster
130 glovebox. TEG was purchased from Sigma-Aldrich
(Milwaukee, Wis, USA). Triphenylphosphine, thioctic acid,
4-(N,N-dimethylamino)pyridine, N,N -dicyclohexylcarbo-
diimide, and N-hydroxysuccinimide were purchased from
Acros Organics (Morris Plains, NJ, USA). Sodium azide
and biotin were purchased from Alfa Aesar (Ward Hill,
Mass, USA). Methanesulfonyl chloride was purchased from
GFS Chemicals (Powell, Ohio, USA). Sodium borohydride
was purchased from Strem Chemicals (Newburyport, Mass,
USA). Alltheotherchemicals(includingsolvents)werepur-
chased from Sigma-Aldrich and Acros Organics. Tetrahy-
drofuran (THF) was dried over CaH2 before use. Deuterated
solvents employed in all NMR measurements were used as
received. Chemical shifts for 1H NMR spectra are reported
relative to tetramethylsilane (TMS) signal in the deuterated
solvent (TMS, δ = 0.00ppm). All J values are reported in
Hertz. Column chromatography was performed on bench
top, using silica gel (Bodman Industries, Aston, Pa, USA,
60 ˚ A, 230–400mesh).
1H NMR spectra were recorded on a Bruker SpectroSpin
400MHz spectrometer. Electronic absorption spectra were
recorded using an HP 8453 diode array spectrophotome-
ter (Agilent technologies, Santa Clara, Calif, USA), while
ﬂuorescence spectra were collected using a Spex Fluorolog-
3 spectrophotometer (Jobin Yvon Inc, Edison, NJ, USA).
To account for the nonlinear (wavelength-dependent) quan-
tum eﬃciency of the PMT detector, the ﬂuorescence spectra
were corrected using calibration curves accounting for the
wavelength-dependence of the PMT’s detection eﬃciency.
2.1. Ligandsynthesis
The biotin-terminated ligands were synthesized stepwise us-
ing commercially available TEG. The choice of a short TEG
segment to test this synthetic scheme was motivated by the
well-deﬁned chain length of the TEG molecules compared to
longer PEG chains, which is expected to make separation us-
ing column chromatography easier. In the following section
we detail the synthesis of each intermediate compound nec-
essaryforpreparationoftheﬁnalDHLA–TEG–biotinligand.
All the compounds were characterized by thin layer chro-
matography (TLC) and 1HN M R .
2.1.1. 1,11-Diazido-3,6,9-trioxaundecane
Diazide-functionalization of TEG (3): compound 3 was pre-
pared following published procedures [13]. TEG (40.0g,
206mmol), tetrahydrofuran (THF) (350mL), and methane-
sulfonyl chloride (53.0g, 463mmol) were mixed in a 1L
round bottom ﬂask and cooled to 0◦C. A solution of triethy-
lamine (49.0g, 484mmol) in THF (50mL) was added drop-
wise over 30 minutes and the mixture was stirred at room
temperature over 20 hours. The reaction was then diluted
with water (200mL) and NaHCO3 (12.5g). Sodium azide
(36.0g,554mmol)wasaddedandthebiphasic reactionmix-
turewasﬁrstheatedto65◦CtodistilloﬀtheTHF,andthento
70◦C for 14 hours. The reaction mixture was cooled to room
temperature and extracted with ether (3×75mL). The com-
bined organic extracts were dried over MgSO4,ﬁ l t e r e d ,a n d
evaporated to give brownish oil. The product was puriﬁed by
ﬂash column chromatography (hexane:EtOAc 1:1) and the
solvent evaporated to give 39g (a yield of 78%) as a color-
less oil. 1H NMR (400MHz, CDCl3): δ (ppm) 3.66–3.71 (m,
12H, –OCH2 CH2–), 3.40 (t, 4H, J = 5.1Hz, –CH2N3).
2.1.2. 1-Amino-11-azido-3,6,9-trioxaundecane
Transformation to monoamine-terminated TEG (4)[ 13]:
1,11-Diazido-3,6,9-trioxaundecane (3) (33.0g, 135mmol)
and 250mL of 0.7 M H3PO4 were placed in a 1L round bot-
tom ﬂask and cooled to 0◦C using an ice bath while stirring.
A solution of triphenylphosphine (PPh3) (29.0g, 110mmol)
in ether (250mL) was slowly added via cannula and the tem-
perature of the reaction was maintained below 5◦C. Once
addition was complete, the reaction mixture was warmed to
room temperature and stirred under nitrogen for an addi-
tional 16 hours. The biphasic solution was separated and the
aqueous layer was washed with ether (3 × 100mL). Potas-
sium hydroxide (KOH) (30g) was slowly added to the aque-
ous layer and cooled to 0◦C overnight. The solution was ﬁl-
tered and the ﬁltrate was basiﬁed with an additional 40g of
KOH and cooled to room temperature. The reaction mixture
was extracted with CHCl3 (4×75mL) and the combined or-
ganic extracts were dried over MgSO4, ﬁltered, and the sol-
vent was evaporated to give 18.5g of an oil with a slight yel-
low color. The monoamine transformation reaction has a
yield of 63%. 1H NMR (400MHz, CDCl3): δ (ppm) 3.57 (m,
10H, –OCH2CH2–), 3.40 (t, 2H, J = 5.2Hz, –CH2CH2NH2),
3.29 (t, 2H, J = 5.0Hz, –CH2N3), 2.75 (t, 2H, J = 5.2Hz, –
CH2CH2NH2).
2.1.3. 5-([1,2]Dithiolan-3-yl)pentanoic
acid-N-(3 ,6 ,9 -trioxaundecane-11
 -azido)amide
Coupling of amino-terminated TEG to thioctic acid:
TA-TEG-N3,c o m p o u n d5: thioctic acid (11.1g, 53.8
mmol), 1-amino-11-azido-3,6,9-trioxaundecane (4) (11.2g,
51.3mmol), 4-dimethylaminopyridine (1.26g, 10.3mmol),
and CH2Cl2 (200mL) were placed in a 500mL round bot-
tom ﬂask, cooled to 0◦C and stirred under N2 atmosphere.
N,N -Dicyclohexylcarbodiimide(DCC)(11.1g,53.8mmol)
was slowly added and reaction mixture was stirred at 0◦C
for 2 hours, then warmed to room temperature and stirred
for an additional 16 hours. The reaction mixture was ﬁltered
over a plug of celite and rinsed with EtOAc. The ﬁltrate was
evaporated and the crude material was puriﬁed by ﬂash col-
umnchromatography(CHCl3 :MeOH97:3astheeluent)to
give11.7g(yieldof56%)ofayellowoil. 1HNMR(400MHz,
CDCl3):δ (ppm)6.15(m,1H,CO–NH),3.50–3.62(m,11H,Kimihiro Susumu et al. 3
–OCH2CH2–a n dC H), 3.47 (t, 2H, J = 5.0Hz, CO–NH–
CH2CH2O–), 3.36 (t, 2H, J = 5.5Hz, CO–NH–CH2–), 3.31
(t, 2H, J = 5.0Hz, –CH2N3), 2.98–3.13 (m, 2H, CH2), 2.32–
2.42 (m, 1H, CH), 2.10 (t, 2H, J = 7.4Hz, –CH 2–CO–NH–),
1.77–1.87 (m, 1H, CH), 1.50–1.68 (m, 4H, CH2), 1.30–1.45
(m, 2H, CH2).
2.1.4. 5-([1,2]Dithiolan-3-yl)pentanoic
acid-N-(3 6 9 -trioxaundecane-11-amino)amide
Transformation to amine-terminated TA-TEG, compound
6:c o m p o u n d5 (11.0g, 27mmol) was dissolved in THF
(150mL) in a 300mL round bottom ﬂask ﬁtted with a con-
denser and nitrogen inlet. PPh3 (15.0g, 81mmol) was added
and the reaction was heated to reﬂux for 20 hours. The re-
action mixture was cooled to room temperature and diluted
with 15mL of water and stirred for an additional 20 hours.
The solvent was evaporated and the crude product was pu-
riﬁed by ﬂash column chromatography. Unreacted PPh3 and
triphenylphosphine oxide were removed with CHCl3 and the
eluent was switched to CHCl3 :MeOH:Et 3N (45:45:10) to
collect the desired product. Removal of the solvent gave 9.0g
(yield of 88%) of gelatinous yellow oil. 1H NMR (400MHz,
methanol-d4): δ (ppm) 3.41–3.59 (m, 12H, –OCH2CH2–),
3.26(t,2H,J =5.1Hz,–CO–NH–CH2–),3.22(m,1H,CH–),
2.97–3.12 (m, 2H, CH2), 2.71 (t, 2H, J = 5.3Hz, –CH2CH2–
NH2),2.32–2.42(m,1H,CH),2.12(t,2H,J =7.4Hz,–CH2–
CO–NH–),1.75–1.85(m,1H,CH),1.47–1.69(m,4H,CH2),
1.29–1.44 (m, 2H, CH2).
2.1.5. TA-TEG-Biotin(7)
Biotinyl-N-hydroxysuccinimide was ﬁrst prepared following
the synthetic procedure previously reported [14–16]. Com-
pound 6 (2.3g, 6.0mmol), biotinyl-N-hydroxysuccinimide
(2.05g, 6.0mmol) were dissolved in DMF (50mL) and
stirred at room temperature under N2 atmosphere. Et3N
(3.0g, 30mmol) was added dropwise via syringe and the re-
action was stirred for 16 hours. The solvent was evaporated
under reduced pressure and the yellow residue was puri-
ﬁed by ﬂash column chromatography (using CHCl3 :MeOH
95:5 as the eluent). The solvent was evaporated to give 3.1g
(a yield of 85%) of viscous yellow oil. 1H NMR (400MHz,
CDCl3): δ (ppm) 6.79 (m, 1H, CO–NH), 6.59 (m, 1H, CO–
NH), 6.49 (s, 1H, biotin CO–NH), 6.02 (s, 1H, biotin CO–
NH), 4.41 (m, 1H, biotin CO–NH–CH), 4.22 (m, 1H, bi-
otin CO–NH–CH), 3.52 (m, 9H, –OCH2CH2–a n dC H),
3.45 (m, 4H, CO–NH–CH2CH2O–), 3.30 (m, 4H, CO–NH–
CH2),2.96–3.10 (m,3H,CH2 andCH–S),2.76–2.83 (m,1H,
CH–S), 2.65 (d, 1H, J = 12.8Hz, CH–S), 2.30–2.40 (m, 1H,
CH), 2.11 (m, 4H, NH–CO–CH 2), 1.75–1.85 (m, 1H, CH),
1.45–1.68 (m, 8H, CH2), 1.26–1.42 (m, 4H, CH2).
2.1.6. DHLA–TEG–biotin(8)
Compound 7 (2.0g, 3.3mmol) was dispersed in a mixture of
ethanol(40mL)andwater(20mL)whilestirringina125mL
ﬂask. NaBH4 (700mg, 18.5mmol) was slowly added and the
solution was stirred at room temperature for 4 hours. The
reaction mixture was diluted with water (200ml) and ex-
tracted with CHCl3 (4 × 50ml), dried over MgSO4, ﬁltered,
andthesolventwasevaporated.Thecrudeproductwaspuri-
ﬁ e db yﬂ a s hc o l u m nc h r o m a t o g r a p h y( C H C l 3 :MeOH95:5
as the eluent) to give 1.53g (a yield of 77%) of colorless vis-
cous oil. 1H NMR (400MHz, CDCl3): δ (ppm) 6.96 (m, 1H,
CO–NH), 6.69 (m, 1H, CO–NH), 6.63 (s, 1H, biotin CO–
NH), 6.03 (s, 1H, biotin CO–NH), 4.37 (m, 1H, biotin CO–
NH–CH), 4.18 (m, 1H, biotin CO–NH–CH), 3.50 (m, 8H, –
OCH2CH2–), 3.42 (m, 4H, CO–NH–CH2CH2O–), 3.29 (m,
4H, CO–NH–CH2), 2.96–3.06 (m, 1H, CH–S), 2.70–2.84
(m, 2H, CH–S and CH–SH), 2.46–2.66 (m, 3H, CH–S and
CH2–SH), 2.07 (m, 4H, NH–CO–CH2), 1.71–1.83 (m, 1H,
CH), 1.35–1.67 (m, 13H, CH2), 1.28 (t, 1H, J = 8.0Hz, CH2–
SH), 1.23 (d, 1H, J = 7.6Hz, CH–SH).
2.2. Quantumdotsynthesisandcapexchange
The CdSe–ZnS core-shell QD’s used were synthesized using
high-temperature reaction of organometallic precursors in a
mixture of TOP/TOPO and alkylamine, as described in the
literature [17–20]. Cap exchange of the TOP/TOPO-capped
QD’s with the newly synthesized ligands to achieve water sol-
ubility (a mixture of 1 and 8, and a mixture of 2 and 8)
was carried out following procedures described previously
[5,12,21]. For capexchangewith a mixture of 2and 8, ∼50–
300mg of TOP/TOPO-capped QD’s were precipitated using
EtOH and the supernatant was discarded. To the precipitate
∼0.5mL in total of pure or mixed ligands and ∼0.5mL of
EtOHwereadded.Themixturewasthenheatedto60∼80◦C
while stirring for a period of 6 to 12 hours. Once homoge-
nized, the sample was then precipitated out with mixtures of
hexane, EtOH, and CHCl3 (approximate ratio is 11:10:1,
this ratio may vary from batch to batch); the precipitate was
dispersed in water. The homogenized solution was further
puriﬁed using 3∼4 cycles of concentration/dilution with an
ultrafree centrifugal ﬁltration device (Millipore, Mw cutoﬀ
∼50,000Da) to remove excess ligands and other materials
from the solution. Cap exchange with a mixture of 1 and 8
was done similarly though some modiﬁcations are required
for puriﬁcation steps. [21]D M F( ∼5mL) was added to the
reaction mixture after the solution was homogenized. The
QD’s were precipitated out by adding excess potassium tert-
butoxide. The mixture was centrifuged and the supernatant
was discarded. The precipitate was dispersed in water and
the homogenized solution was further puriﬁed as described
above.
2.3. Gelelectrophoresis
Samples were separated in agarose gels as described previ-
ously [22]. Brieﬂy, samples were mixed with 30% glycerol,
loaded into 1.5% agarose gels buﬀered with 1X Tris borate
EDTA (TBE) in TBE running buﬀer (pH ∼8.3) and run at
10volts/cm for ∼1 hour at ambient temperature. The gel-
shift bands were visualized using the QD photoluminescence
collected on a Kodak 440 Digital Image Station (Rochester,
NY, USA) equipped with a long-pass cutoﬀ ﬁlter; samples
were illuminated with UV light (365nm excitation).4 Journal of Biomedicine and Biotechnology
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Figure 1: Chemical structures and synthetic routes of the surface ligands used in this study: (A) (i) MsCl, Et3N, THF, 0◦C→20◦C, 20 hours;
(ii)NaN3,N aHCO 3,H 2O, 70◦C,14hours;(B)PPh3,0.7MH 3PO4,Et 2O, <5◦ →roomtemperature,16hours;(C)DCC,DMAP,CH2Cl2,0 ◦C,
2hour →roomtemperature,20hours;(D)PPh3,H 2O,THF,reﬂux,20hour→roomtemperature,20hours;(E)Biotin N-hydroxysuccinimide
ester, Et3N, DMF, room temperature, 16 hours; (F) NaBH4,E t O H ,H 2O, room temperature, 4 hours.
2.4. Surfacebindingassay
The binding capacity of NeutrAvidin-covered 96-well mi-
crotiter ﬂat-bottom plates from Pierce Biotechnology is 60
picomoles of biotin per well. 100μLa l i q u o t so fQ Ds a m -
ples (with the desired cap mixture at ∼7p Mc o n c e n t r a -
tion) were added to the wells and let incubate overnight
at room temperature. The ﬂuorescence intensity was mea-
sured using a Tecan Saﬁre Dual Monochromator Multifunc-
tion Microtiter Plate Reader (Tecan, Research Triangle Park,
NC, USA), then plates were washed 3 times with 10mM Na
tetraborate buﬀer (pH 9) supplemented with 0.02% Tween
and the ﬂuorescence signal was measured again; 300nm ex-
citation line was used for all the samples. The remaining ﬂu-
orescence intensities were calculated as approximate binding
percentages. Those values were normalized by setting the
highest binding percentage to 100%.
3. RESULTS AND DISCUSSION
The chemical structures and synthetic schemes of a few
representative ligands (namely DHLA, DHLA–PEG600, and
DHLA–TEG–biotin)andreactionstepsinvolvedaresumma-
rized in Figure 1. TEG was ﬁrst transformed into diazide-
terminated-TEG(3)usingatwo-stepreactionwithmethane-
sulfonyl chloride and sodium azide. Monosubstitution of
one azide into an amine group was carried out in bipha-
sic acidic solution to improve the eﬃciency of selective
formation of the monsubstituted product (4)[ 13]. Thioc-
tic acid (TA) and N3–TEG–NH2 (4)w e r ec o u p l e dw i t h
N,N -dicyclohexylcarbodiimide (DCC) to provide azide-
terminated compound 5. The terminal azido group of 5 was
reduced with PPh3 and H2O to obtain an amine-terminated
TA-TEG ligand (Compound 6). Biotin-functionalized com-
pound 7 was synthesized by coupling between 6 and Bi-
otin N-hydroxysuccinimide ester. Finally, the terminal 1,2-
dithiolanegroupincompound7wasreducedwithNaBH4 to
obtain DHLA terminal group as a bidentate thiol anchoring
unit.
We veriﬁed quality of the new compounds by collecting
1H-NMR spectra throughout the various steps employed.
The 1H-NMR spectra show that TEG-modiﬁed compounds
have large peaks around ∼3.6ppm, which are ascribed to
CH2 groups of TEG chains. After coupling between 6 and
biotin N-hydroxysuccinimide ester, new distinct multiplet
peaks (2.6∼2.9, 4.22, and 4.41ppm) are measured in the
NMR spectra, which were ascribed to biotin-ring protons.
In addition, following reduction of the 1,2-dithiolane group
with NaBH4, new doublet and triplet peaks appeared at 1.23
and 1.28ppm, respectively. These two peaks were assigned
as thiol protons of DHLA unit (open dithiol) [12]. The ob-
served changes in each collected spectrum indicate that each
reaction step produced the desired compound.
We have previously shown that QD’s capped with
DHLA–PEG600 or DHLA–PEG1000 ligands can be dis-
persedinbuﬀerswithpHrangingbetween5∼12[12].How-
ever, cap exchange of TOP/TOPO with DHLA–TEG–biotin
alone did not produce water-soluble QD’s, a property at-
tributable to the rather short TEG segment combined with
the hydrophobic nature of the biotin group [12]. To achieveKimihiro Susumu et al. 5
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Figure 2: Gel shift of 510-nm emitting CdSe–ZnS QD’s coated
with diﬀerent ligands in 1.5% agarose gel buﬀered with TBE buﬀer:
(A,E) DHLA; (B) DHLA–PEG600; (C) DHLA:DHLA–TEG–Biotin
(7:1); (D) DHLA–PEG600:DHLA–TEG–Biotin (7:1).
water solubility using the new DHLA–TEG–biotin ligands
(compound 8), TOP/TOPO-capped QD’s were instead dis-
persed (during cap exchange) with mixtures of ligand 8 and
either DHLA (1) or DHLA–PEG600 (2). Rather low to mod-
est DHLA–TEG–biotin ratios (5–25%) wereused in the mix-
tures for cap exchange. In addition to promoting easy trans-
ferintobuﬀersolutions,thisapproachensuresthatonlycon-
trolled and low density of biotin groups are available on each
QD. This should also allow control over the number of bio-
logical receptors coupled to a single QD and potentially bi-
ological activity of the QD-bioconjugates. In this particular
study, we used a mixture of compound 1 and compound 8
(at7:1molarratio),andamixtureofcompound2andcom-
pound 8 (at 7:1 molar ratio) for the cap exchange.
In the ﬁrst characterization experiment of the cap ex-
change, we monitored changes in the electrophoretic mo-
bility of QD’s (run on a 1.5% agarose gel) as a function
of the capping mixture used. The gel image in Figure 2
shows a side-by-side comparison of the mobility shift of
510nm emitting QD cap exchanged with either a mixture
of DHLA:DHLA–TEG–biotin (7:1) (lane C) or a mixture
of DHLA–PEG600:DHLA–TEG–biotin (7:1) (lane D), to-
gether with control samples made of either QD’s capped
with DHLA (lanes A and E) or QD’s capped with DHLA–
PEG600 (lane B). The data clearly show that on the one
hand QD’s capped with only DHLA experienced the high-
est mobility shift (towards the positive electrode) in this
series; this result is attributed to the presence of carboxyl
groups on DHLA molecules, which can be deprotonated
and negatively charged in basic buﬀer solutions. On the
other hand, DHLA–PEG600-capped QD’s showed no mo-
bility shift under applied voltage (materials did not migrate
from the loading well), indicating that these QD’s are essen-
tially neutral; water solubility for this sample is mainly pro-
moted by hydrophilicity of the long PEG chains. In compari-
son, the gel shift of the QD with DHLA:DHLA–TEG–Biotin
(7:1)wasslightlylowerthanthatoftheDHLA-cappedQD’s,
whereas QD’s capped with DHLA–PEG600:DHLA–TEG–
Biotin (7:1) mixture showed a very small shift compared
with DHLA–PEG600-capped QD’s. For QD’s capped with
5.566 .577 .588 .59
pH
Figure 3: Luminescence image set of 540nm emitting CdSe–ZnS
QD with DHLA–PEG600:DHLA–TEG–Biotin (4:1) at pH 5.5∼9
in phosphate buﬀer saline at various pH values at room tempera-
ture. Samples were excited with a handheld UV lamp at 365nm.
DHLA:DHLA–TEG–Biotin (7:1) mixture, partial occupa-
tion of the nanocrystal surface by DHLA–TEG–Biotin (com-
pared with DHLA-capped QD’s) has led to reduced num-
ber of charges per QD and thus small reduction in the gel
mobility shift (lane C). The nonzero mobility shift (even
though extremely small) measured for QD’s capped with a
mixture of DHLA–PEG600:DHLA–TEG–Biotin may be due
to a slight/partial charging of biotin or amide groups on the
chain under applied voltage. Overall, the present gel elec-
trophoresis data conﬁrm that cap exchange of TOP/TOPO-
capped QD’s with a ligand mixture produced nanocrystals
that have both types of capping ligands; furthermore, the
overall relative proportions of each ligand used during cap
exchange is preserved in the ﬁnal QD samples.
Absorption and ﬂuorescence spectra were measured for
both the native TOP/TOPO-capped QD’s in toluene and the
new hydrophilic QD’s capped with DHLA–TEG derivatives
in H2O (data not shown). Absorption spectra measured be-
fore and after the cap exchange were essentially unchanged,
thoughafewnmredshiftofthelowestabsorptionmaximum
of the hydrophilic QD’s was occasionally measured com-
pared with that of QD’s capped with TOP/TOPO ligands.
The ﬂuorescence spectra showed similar trends. These occa-
sional small changes in the optical properties of QD’s follow-
ing transfer into aqueous solutions are commonly observed
[1, 12, 23]. The ﬂuorescence quantum yields of the water-
dispersed QD’s change from batch to batch. The quantum
yields in aqueous solutions (after cap exchange and transfer)
are ∼50% of the original values measured for TOP/TOPO-
capped QD’s in organic solutions. The overall quantum yield
of the hydrophilic QD’s thus varies anywhere between 10–
40%.
QD’s cap-exchanged with mixture containing the new
DHLA–TEG–biotin ligands were also stable and aggregate-
free over extended periods of time (months). Figure 3 shows
solutions of QD’s capped with a mixture of compound 2 and
compound8(7:1)inH2OofwhichpHrangedfrom5.5to9.
Thenewwater-solubleQD’swerestableandwelldispersedin
the wide pH range including acidic conditions. This feature
is quite diﬀerent from what we have observed for solutions6 Journal of Biomedicine and Biotechnology
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Figure 4: Surface binding plate assay of QD’s with diﬀerent surface
ligands: (1) DHLA, (2) DHLA–PEG600, (3) DHLA:DHLA–TEG–
Biotin (at 4:1 ratio), and (4) DHLA–PEG600:DHLA–TEG–Biotin
(at 4:1 ratio). 540nm emitting QD’s were used.
of QD’s capped with either DHLA or mercaptoundecanoic
acid(MUA).TheDHLA-orMUA-cappedQDsolutionswere
well dispersed in aqueous basic media but showed aggrega-
tion and eventual precipitation at pH lower than 7 (data not
shown), indicating that deprotonation of carboxyl groups is
a crucial factor to solubilize those QD’s in aqueous solutions.
Incontrast,appendingashortPEGchainattheendofDHLA
molecules extended the stability of QD capped with either
100% DHLA–PEG600 or a mixture of DHLA–PEG600 and
Biotin-functionalized DHLA–TEG to acidic buﬀer solutions.
Once cap exchange with biotin-terminated DHLA–TEG
and transfer into aqueous environment was successfully real-
ized, targeted biological assays were carried out. The binding
properties of QD’s partially capped with biotin-terminated
DHLA–TEG (8) were investigated for their ability to interact
with NeutrAvidin-functionalized substrates [24]. NeutrA-
vidin, which is a deglycosylated form of avidin, was chosen
duetoitslownonspeciﬁcinteractions(comparedwithavidin
orstreptavidin)whilemaintainingthestrongbindingaﬃnity
with biotin [24]. Following incubation of the NeutrAvidin-
functionalized substrates with the QD samples, substrates
were rinsed 3 times with borate buﬀer with Tween and the
ﬂuorescence signals were collected. Figure 4 shows the ﬂu-
orescence intensities measured for 4 diﬀerent QD solutions
incubated with NeutrAvidin-coated plates: one capped with
DHLA (1), one capped with DHLA–PEG600 (2), one capped
with a mixture of 1 and DHLA–TEG–Biotin (8) (at 4:1 ra-
tio),andonecappedwithamixtureof 2and8(at4:1ratio).
The data clearly show that only substrates incubated with
QD’s that were capped with a mixture of biotin-terminated
DHLA–TEG produced a large signal-to-background ﬂuo-
rescence signal. In comparison, the substrates incubated
with DHLA- or DHLA–PEG600-capped QD’s produced only
background contribution to the signal. This result indicates
that eﬃcient and speciﬁc interactions between the biotin
groups present on the QD surface and NeutrAvidin on the
substrate drive the surface capture of the nanocrystals. It is
important to note that the QD’s capped with DHLA–TEG–
biotin alone were, however, not dispersible in buﬀer solu-
tions, a result we attribute to the poor water compatibility of
biotinbyitselfandtheshortTEG.Weareexploringtheuseof
longer chain PEG segments for insertion between the dithiol
group and biotin. This should make dispersion in buﬀer so-
lution achievable even at high biotin fractions and promote
strong interactions with NeutrAvidin. Those ﬁndings will be
discussed in future reports.
4. CONCLUSION
We have demonstrated simple and eﬃcient synthetic pro-
cedures to prepare new biotin-functionalized ligands based
on the DHLA motif and employing short TEG segment.
The present synthetic route provided high quality and stable
compounds, which were further employed to make biotin-
functionalized luminescent QD’s, using easy-to-implement
cap exchange procedure. The new biotin-appended ligand
mixed with either DHLA or DHLA–PEG600 eﬀectively cap
exchanged with the native TOP/TOPO and provided QD’s
that are water-soluble over extended periods of time and
biologically active. QD’s cap-exchanged with a mixture of
DHLA–PEG600 (neutral) and DHLA–TEG–biotin showed
speciﬁc interactions with NeutrAvidin in surface binding as-
says.Thepresentsyntheticmethodologiesofhydrophilicsur-
face ligands and cap-exchange reactions promise access to a
variety of biological entities. Further studies of these surface-
functionalized QD’s for coupling with a variety of biorecep-
tors and biological assays are in progress.
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